antisynthetase syndrome
antisynthetase syndrome
Explore linked clinical trials. Standard reference: MONDO:00193447 results ยท Page 1 of 1
Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| A Study to Assess the Long-term Safety and Efficacy of a Subcutaneous Formulation of Efgartigimod in Adults With Active Idiopathic Inflammatory Myopathy | Skin and Connective Tissue Diseases, antisynthetase syndrome, connective tissue disorder, dermatomyositis, immune-mediated necrotizing myopathy, muscle tissue disorder, musculoskeletal system disorder, myositis disease, nervous system disorder, neuromuscular disease, polymyositis, skin disorder | Enrolling by invitation | Phase 3 | 2026-09-21 | NCT05979441 | |
| Descartes-08 in Autoantibody Myositis | antisynthetase syndrome, muscle tissue disorder, musculoskeletal system disorder, myositis disease, nervous system disorder, neuromuscular disease | Recruiting | Phase 2 | 2026-08-17 | NCT07391605 | |
| BCMA-CD19 cCAR-T for the Treatment of Refractory Inflammatory Myopathy | Skin and Connective Tissue Diseases, antisynthetase syndrome, connective tissue disorder, dermatomyositis, muscle tissue disorder, musculoskeletal system disorder, myositis disease, nervous system disorder, neuromuscular disease, polymyositis, skin disorder | Recruiting | Phase 1 | 2026-07-20 | NCT07715136 | |
| A Study on the Efficacy and Safety of JAK Inhibitors Versus Calcineurin Inhibitors as Initial Therapy for Interstitial Lung Disease Associated With Antisynthetase Syndrome | antisynthetase syndrome, interstitial lung disease, lung disorder, respiratory system disorder | Recruiting | Not applicable | 2026-06-03 | NCT07406932 | |
| Add-on Intravenous Immunoglobulins in Early Myositis | Skin and Connective Tissue Diseases, acquired idiopathic inflammatory myopathy, antisynthetase syndrome, connective tissue disorder, dermatomyositis, immune-mediated necrotizing myopathy, muscle tissue disorder, musculoskeletal system disorder, myositis disease, nervous system disorder, neuromuscular disease, polymyositis, skin disorder | Active, not recruiting | Phase 2 / Phase 3 | 2026-02-27 | NCT05832034 | |
| An Exploratory Clinical Study of CD19 CAR NK Cells for the Treatment of Refractory Antisynthetase Antibody Syndrome and Rheumatoid Arthritis | Skin and Connective Tissue Diseases, antisynthetase syndrome, arthritic joint disease, arthropathy, autoimmune disease, connective tissue disorder, immune system disorder, musculoskeletal system disorder, rheumatic disorder, rheumatoid arthritis | Recruiting | Early phase 1 | 2025-04-30 | NCT06613490 | |
| Optimizing Treatment on Idiopathic Inflammatory Myopathies | Skin and Connective Tissue Diseases, acquired idiopathic inflammatory myopathy, antisynthetase syndrome, connective tissue disorder, dermatomyositis, muscle tissue disorder, musculoskeletal system disorder, myositis disease, nervous system disorder, neuromuscular disease, polymyositis, skin disorder | Recruiting | Not stated | 2024-12-05 | NCT03092180 |